Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02529709 · ClinicalTrials.gov registry record · NA

The Effect of Meal Composition on Blood Lipids

A NA study of Dyslipidemia, sponsored by Texas Christian University.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT02529709: Completed NA study of Dyslipidemia, sponsored by Texas Christian University.

NCT02529709 is a NA study of Dyslipidemia that has completed, run by Texas Christian University. The registered enrollment target is 24 participants, below the 362-participant average among 40 other Dyslipidemia trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02529709, a NA study of Dyslipidemia, has completed, sponsored by Texas Christian University.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see if a high-protein meal leads to a better postprandial (after a meal) blood lipid profile compared to a high-monounsaturated meal.

Conditions Studied

Interventions

  • OTHER High-Protein Condition
  • OTHER High-Monounsaturated Fat Condition

Study Locations (1)

Texas

  • Texas Christian University - Fort Worth

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2015-10
Est. Completion 2016-04
Phase NA
Texas Christian University

26 total trials

What the finished NCT02529709 record still lists

NCT02529709 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 362-participant average among 40 other Dyslipidemia trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Dyslipidemia appearing as the primary indexed condition, and to 2 interventions - of which High-Protein Condition is the first listed.

NCT02529709 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT02529709 about?

NCT02529709 is a clinical study titled "The Effect of Meal Composition on Blood Lipids". The purpose of this study is to see if a high-protein meal leads to a better postprandial (after a meal) blood lipid profile compared to a high-monounsaturated meal.

What is the current status of trial NCT02529709?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2015-10. Estimated completion is 2016-04.

What conditions does trial NCT02529709 study?

This clinical trial studies the following conditions: Dyslipidemia.

What interventions are being tested in trial NCT02529709?

The interventions under investigation include: High-Protein Condition (OTHER), High-Monounsaturated Fat Condition (OTHER).

Who is sponsoring clinical trial NCT02529709?

This trial is sponsored by Texas Christian University, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02529709 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dyslipidemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02529709's enrollment target sits among peer trials

24 36th of 40 higher than 4 of 40 other Dyslipidemia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dyslipidemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02529709, the US trial registry maintained by the National Library of Medicine. NCT02529709 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.